Development and validation of a new capillary zone electrophoresis method for the assay of ondansetron

Farmacia

Volumn 59, Issue 1, 2011, Pages 34-43

  Aramǎ, Corina ^a   Varvara, Andreea ^b   Monciu, Crina Maria ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b National Medicines Agency   (Romania)

Author keywords

Capillary zone electrophoresis; Ondansetron hydrochloride assay

Indexed keywords

ELECTROLYTE; ONDANSETRON; PHOSPHATE BUFFERED SALINE;

ACCURACY; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; DRUG DETERMINATION; DRUG IMPURITY; DRUG SELECTIVITY; ELECTRIC POTENTIAL; VALIDATION PROCESS;

EID: 79951799127     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. th Edition, Strasbourg, 2008;
2. XXX, Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH Harmonised Tripartite Guideline, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, November 2005
3. Burm J-P., Jhee, S.S., Moon Z.S.K., Jeong E., Nii L., Fox J.L., Gill M.A., Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration, Am. J. Health-Syst.Pharm. 1994, 51, 1201-1204
4. Chung K.C., Moon Y.S.K., Ulrich R.W., Gill M.A., Compatibility of ondansetron hydrochloride and piperacillin sodium tazobactam sodium during simulated Y-site administration, Am. J. Health-Syst.Pharm. 1995, 52, 1554-1556
5. Li, H.; Shi, W.; You, H., Determination of ondansetron in injection by high performance capillary zone electrophoresis, Chinese Journal of Chromatography 1998, 16(3), 250-251
6. Salem I.I., Lopez Ramos J.M., Galan Cerezo A., Ondansetron hydrochloride, Anal. Profiles Drug Subst. Excipients 2001, 27, 301-338
7. Siluveru M, Stewart J.T., Enantioselective determination of S-(+)- and R-(-)-ondansetron in human serum using derivatized cyclodextrin-modified capillary electrophoresis and solid-phase extraction, Journal of Chromatography B: Biomedical Sciences and Applications 1997, 691 (1), 217-222 (Pubitemid 27168860)
8. Varvara A., Monciu C-M., Aramǎ C., Popescu C., A new stationary phase in the liquid chromatographic assay of ondansetron hydrochloride, Farmacia, 2007, 55 (2), 121-131
9. Varvara A., Monciu C-M., Aramǎ C., Popescu C., The HPLC assay of ondansetron hydrochloride and its impurities using a new stationary phase, Farmacia, 2008, 56 (2), 154-165 (Pubitemid 351611715)
10. Varvara A., Monciu C-M., Aramǎ C., Popescu C., Ion-pair reversed-phase high performance liquid chromatography of ondansetron hydrochloride using sodium heptanesulphonate as a counterion, Farmacia, 2009, 57 (4), 442-451
11. Varvara A., Monciu C-M., Aramǎ C., Popescu C., Application of selective bonded phase in the liquid chromatographic assay of ondansetron hydrochloride and its impurities, Farmacia, 2009, 57 (5), 570-581,http://www. sciencedirect.com/science/journal/15700232
12. Zhou, Y.; Feng F., Zhang Z.-X., Enantioselective determination of two enantiomers of ondansetron in rat plasma by HPCE and their stereoselective pharmacokinetic study in rats, Chinese Pharmaceutical Journal 2006, 41 (7), 541-544 (Pubitemid 44734782)
13. www.raell.daemon.co.uk/chem/logp/logppka.html, accessed: November 14th 2008